Insmed Inc. buy Rothschild & Co Redburn
Start price
04.12.25
/
50%
€179.00
Target price
04.12.26
€225.50
Performance (%)
-49.50%
Price
08:32
?
Summary
This prediction is currently active. The BUY prediction by Rothschild___Co_Redb for Insmed Inc. is performing very badly with a performance of -49.50%. This prediction currently runs until 04.12.26. The prediction end date can be changed by Rothschild___Co_Redb at any time. Rothschild___Co_Redb has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -2.283% | -2.283% |
| iShares Core DAX® | 1,01 % | 2,70 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % |
| iShares S&P 500 | -2,72 % | -1,75 % |
Comments by Rothschild___Co_Redb for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $263.00 price target on the stock.
Ratings data for INSM provided by MarketBeat